EcoDrugPlus

Natriuretic Peptide Receptor 1

Ensembl ID : ENSJJAG00000021087
Gene Symbol: NPR1
3 Cross references
184 Possible Orthologues:

Natriuretic Peptide Receptor 2

Ensembl ID : ENSJJAG00000021290
Gene Symbol: NPR2
3 Cross references
259 Possible Orthologues:

Natriuretic Peptide Receptor 3

Ensembl ID : ENSJJAG00000015675
Gene Symbol: NPR3
3 Cross references
211 Possible Orthologues:

Neuropeptide Y Receptor Y5

Ensembl ID : ENSJJAG00000012516
Gene Symbol: NPY5R
3 Cross references
135 Possible Orthologues:

Neurotensin Receptor 1

Ensembl ID : ENSJJAG00000019264
Gene Symbol: NTSR1
3 Cross references
211 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 1

Ensembl ID : ENSJJAG00000019787
Gene Symbol: NTRK1
3 Cross references
199 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 2

Ensembl ID : ENSJJAG00000021752
Gene Symbol: NTRK2
3 Cross references
286 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 3

Ensembl ID : ENSJJAG00000015374
Gene Symbol: NTRK3
3 Cross references
269 Possible Orthologues:

Nicastrin

Ensembl ID : ENSJJAG00000020273
Gene Symbol: NCSTN
3 Cross references
203 Possible Orthologues:

Nicotinamide Phosphoribosyltransferase

Ensembl ID : ENSJJAG00000016495
Gene Symbol: NAMPT
3 Cross references
235 Possible Orthologues:

Nischarin

Ensembl ID : ENSJJAG00000013344
Gene Symbol: NISCH
3 Cross references
209 Possible Orthologues:

Nitric Oxide Synthase 2

Ensembl ID : ENSJJAG00000008903
Gene Symbol: NOS2
3 Cross references
163 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).